Literature DB >> 10375083

Testicular lymphoma.

N Shahab1, D C Doll.   

Abstract

Non-Hodgkin's lymphoma of the testis is an uncommon disease. It accounts for approximately 9% of testicular neoplasms. Despite this low overall incidence, however, it is the most common testicular malignancy in the elderly. Testicular lymphoma has a rather high incidence of bilateral involvement and a propensity for extranodal spread to the skin, subcutaneous tissue, CNS, lung, and Waldeyer's ring. Although intermediate-grade diffuse large B-cell lymphoma is the most common histologic pattern among primary testicular lymphoma, secondary infiltration of the testis, especially in high-grade Burkitt's lymphoma, is more prevalent. Although excellent results with a doxorubicin-containing chemotherapy regimen have been achieved in early-stage disease, patients with advanced disease have a grave prognosis.

Entities:  

Mesh:

Year:  1999        PMID: 10375083

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  29 in total

1.  [B-cell lymphoma of the testes].

Authors:  V Zugor; M Frank; F S Krause; G E Schott; T Aigner; D G Engehausen
Journal:  Urologe A       Date:  2006-10       Impact factor: 0.639

2.  Diagnosis of a primary testicular lymphoma by echography and magnetic resonance imaging.

Authors:  Alejandro Vara Castrodeza; Angeles Torres Nieto; Marcelino Mendo González; Antonio Rodríguez Toves; María Jesús Peñarrubia Ponce; Miguel Angel de la Fuente Bobillo
Journal:  Clin Transl Oncol       Date:  2006-06       Impact factor: 3.405

3.  Efficacy of prophylactic irradiation to the contralateral testis for patients with advanced-stage primary testicular lymphoma: an analysis of outcomes at a single institution.

Authors:  Ryouji Tokiya; Eisaku Yoden; Kei Konishi; Nobuhiko Kamitani; Junichi Hiratsuka; Risa Koresawa; Tadashi Hirose; Fuminori Sano; Hirotoshi Tokunaga; Toshinori Kondo; Hideho Wada; Takashi Sugihara
Journal:  Int J Hematol       Date:  2017-06-13       Impact factor: 2.490

4.  Primary testicular and intraocular lymphomas: two case reports and a review of the literature.

Authors:  Dana J Wallace; Chandra R Altemare; De Fen Shen; Marc D deSmet; Ronald R Buggage; Robert B Nussenblatt; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2006 Jan-Feb       Impact factor: 6.048

5.  Unusual presentation of large B cell lymphoma- bone and stomach- treated with autologous transplantation.

Authors:  Bokyung Kim; Sung Yong Oh; Suee Lee; Hyuk-Chan Kwon; Sung-Hyun Kim; Sook Hee Hong; Sung-Soo Kim; Hyo-Jin Kim
Journal:  Cancer Res Treat       Date:  2007-12-31       Impact factor: 4.679

6.  Diagnosis of systemic metastatic retinal lymphoma.

Authors:  Xiaoguang Cao; Defen Shen; David G Callanan; Manabu Mochizuki; Chi-Chao Chan
Journal:  Acta Ophthalmol       Date:  2011-03       Impact factor: 3.761

7.  Non-Hodgkin's lymphoma of the testicle and bilateral adrenals detected by (18)F-FDG PET/CT.

Authors:  Yafu Yin; Feng Qing; Xuena Li; Bulin DU; Na Li; Yaming Li
Journal:  Exp Ther Med       Date:  2011-06-29       Impact factor: 2.447

8.  Primary testicular non-Hodgkin's lymphoma associated with hemophagocytic syndrome: Case report and review of the literature.

Authors:  Weigang Ren; Zhaohui Zhong; Xiaokun Zhao; Junjie Yang; Lei Zhang; Ran Xu; Songchao Li; Xuan Zhu; Chen Lu; Joseph L Chin
Journal:  Oncol Lett       Date:  2012-04-30       Impact factor: 2.967

9.  Three prognostic factors influence clinical outcomes of primary testicular lymphoma.

Authors:  Yu Wang; Zhi-Ming Li; Jia-Jia Huang; Yi Xia; Heng Li; Ya-Jun Li; Ying-Jie Zhu; Wei Zhao; Xi-Ya Xia; Wen-Xiao Wei; Hui-Qiang Huang; Tong-Yu Lin; Wen-Qi Jiang
Journal:  Tumour Biol       Date:  2012-09-11

10.  Rituximab plus a CHOP-like regimen, central nervous system prophylaxis, and contralateral testicular irradiation for localized primary testicular diffuse large B-cell lymphoma lead to prolonged progression-free survival.

Authors:  Kunimoto Ichikawa; Masaaki Noguchi; Michiaki Koike; Nanae Aritaka; Yasunobu Sekiguchi; Yoshitaka Sunami; Miyuki Tsutsui; Masaru Hosone; Takao Hirano; Akihiko Gotoh; Norio Komatsu
Journal:  Int J Hematol       Date:  2014-08-02       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.